{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:38:38Z","timestamp":1780555118971,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH U01-AI70976, R01AI088250, and the WHO HQPOL0801925"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.101","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T13:45:29Z","timestamp":1386942329000},"page":"558-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A mucosal adjuvant for the inactivated poliovirus vaccine"],"prefix":"10.1016","volume":"32","author":[{"given":"Benjamin P.","family":"Steil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Jorquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janny","family":"Westdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried A.M.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Barro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (11)","key":"10.1016\/j.vaccine.2013.11.101_bib0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"American Journal of Epidemiology"},{"issue":"19","key":"10.1016\/j.vaccine.2013.11.101_bib0010","first-page":"353","article-title":"Progress toward interruption of wild poliovirus transmission \u2013 worldwide, January 2011\u2013March 2012","volume":"61","author":"Mdodo","year":"2012","journal-title":"MMWR"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.101_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2005.09.015","article-title":"One hundred years of poliovirus pathogenesis","volume":"344","author":"Racaniello","year":"2006","journal-title":"Virology"},{"issue":"46","key":"10.1016\/j.vaccine.2013.11.101_bib0020","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1016\/j.vaccine.2011.08.059","article-title":"Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission","volume":"29","author":"Okayasu","year":"2011","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.11.101_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2013.11.101_bib0030","first-page":"973","article-title":"Interrupting the transmission of wild polioviruses with vaccines: immunological considerations","volume":"72","author":"Ghendon","year":"1994","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.101_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.101_bib0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2012","journal-title":"Risk Analysis"},{"issue":"10","key":"10.1016\/j.vaccine.2013.11.101_bib0045","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1086\/651952","article-title":"Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination","volume":"201","author":"Grassly","year":"2010","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.vaccine.2013.11.101_bib0050","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jis241","article-title":"Waning intestinal immunity after vaccination with oral poliovirus vaccines in India","volume":"205","author":"Grassly","year":"2012","journal-title":"Journal of Infectious Diseases"},{"issue":"14","key":"10.1016\/j.vaccine.2013.11.101_bib0055","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.101_bib0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1749-6632.1995.tb44442.x","article-title":"Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines","volume":"754","author":"Ogra","year":"1995","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.11.101_bib0065","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1086\/593310","article-title":"New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis","volume":"47","author":"Chumakov","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2013.11.101_bib0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/596052","article-title":"Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota","volume":"199","author":"Alexander","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0075","first-page":"210","article-title":"Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine","volume":"80","author":"Kohler","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.101_bib0080","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annual Review of Microbiology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.101_bib0085","first-page":"23","article-title":"Immunization with live attenuated poliovirus vaccine","volume":"101","author":"Krugman","year":"1961","journal-title":"American Journal of Diseases of Children"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.11.101_bib0090","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/605330","article-title":"Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India","volume":"200","author":"Grassly","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0095","series-title":"Vaccines","first-page":"605","article-title":"Poliovirus vaccine-inactivated","author":"Plotkin","year":"2008"},{"issue":"7","key":"10.1016\/j.vaccine.2013.11.101_bib0100","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1586\/erv.09.49","article-title":"Future of polio vaccines","volume":"8","author":"Ehrenfeld","year":"2009","journal-title":"Expert Review of Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.101_bib0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/risa.12031","article-title":"Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs","volume":"33","author":"Duintjer Tebbens","year":"2012","journal-title":"Risk Analysis"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2013.11.101_bib0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/499970","article-title":"1,25-Dihydroxyvitamin D3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice","volume":"193","author":"Ivanov","year":"2006","journal-title":"Journal of Infectious Diseases"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2013.11.101_bib0115","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0600287103","article-title":"Mucosal and systemic adjuvant activity of alphavirus replicon particles","volume":"103","author":"Thompson","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.11.101_bib0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.181.1.574","article-title":"Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node","volume":"181","author":"Thompson","year":"2008","journal-title":"Journal of Immunology"},{"issue":"33","key":"10.1016\/j.vaccine.2013.11.101_bib0125","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.vaccine.2008.05.046","article-title":"Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen","volume":"26","author":"Thompson","year":"2008","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.vaccine.2013.11.101_bib0130","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.vaccine.2012.04.030","article-title":"Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles","volume":"30","author":"Tonkin","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2013.11.101_bib0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.vaccine.2012.12.076","article-title":"Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains","volume":"31","author":"Westdijk","year":"2013","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.11.101_bib0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/JVI.74.1.371-378.2000","article-title":"Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles","volume":"74","author":"Davis","year":"2000","journal-title":"Journal of Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.101_bib0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.101_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0042-6822(91)90114-Q","article-title":"Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone","volume":"183","author":"Davis","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0155","first-page":"119","article-title":"Potency testing of killed polio vaccine in rats","volume":"47","author":"van Steenis","year":"1981","journal-title":"Developments in Biological Standardization"},{"issue":"18","key":"10.1016\/j.vaccine.2013.11.101_bib0160","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.vaccine.2010.02.010","article-title":"Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization","volume":"28","author":"Tonkin","year":"2010","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.11.101_bib0165","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1084\/jem.167.4.1350","article-title":"Heterogeneity of helper\/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes","volume":"167","author":"Boom","year":"1988","journal-title":"Journal of Experimental Medicine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.11.101_bib0170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00210-13","article-title":"Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri","volume":"20","author":"Kim","year":"2013","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0175","article-title":"Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses","volume":"May","author":"Kimoto","year":"2013","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2013.11.101_bib0180","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF02919728","article-title":"The preference for switching to expression of the IgA isotype of antibody exhibited by B lymphocytes in Peyer's patches is likely due to intrinsic properties of their microenvironment","volume":"10","author":"Cebra","year":"1991","journal-title":"Immunologic Research"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.11.101_bib0185","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0190","first-page":"9","article-title":"Cost analysis of post-polio certification immunization policies","volume":"82","author":"Sangrujee","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"39","key":"10.1016\/j.vaccine.2013.11.101_bib0195","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1016\/j.vaccine.2008.07.011","article-title":"The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines","volume":"26","author":"Thompson","year":"2008","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2013.11.101_bib0200","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1128\/JVI.01650-08","article-title":"Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge","volume":"83","author":"LoBue","year":"2009","journal-title":"Journal of Virology"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2013.11.101_bib0205","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"9420","key":"10.1016\/j.vaccine.2013.11.101_bib0210","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man","volume":"363","author":"MacLennan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0215","first-page":"881","article-title":"Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status","volume":"137","author":"John","year":"2013","journal-title":"Indian Journal of Medical Research"},{"key":"10.1016\/j.vaccine.2013.11.101_bib0220","series-title":"Polio Global Eradication Initiative","year":"2013"},{"issue":"5","key":"10.1016\/j.vaccine.2013.11.101_bib0225","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2013.11.101_bib0230","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2010.11.024","article-title":"Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone\u00ae in rhesus macaques","volume":"29","author":"Carroll","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13016964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T06:50:22Z","timestamp":1538981422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13016964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13016964"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mucosal adjuvant for the inactivated poliovirus vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}